Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)
Status:
Completed
Trial end date:
2012-04-09
Target enrollment:
Participant gender:
Summary
This study is being done to evaluate the safety, efficacy, and dose level of sitagliptin
(MK-0431/ONO-5435) used once daily (qd) in Japanese participants with impaired glucose
tolerance who have inadequate glycemic control using diet and exercise therapy.